Pure Global
NCT06015594

Metformin Treatment in Adolescent Patients With PCOS: A Long-term, Winning Metabolic Choice.

Metformin Treatment in Adolescent Patients With PCOS: A Long-term, Winning Metabolic Choice. Results From a Single Center 5-years Retrospective Clinical Study
University of Cagliari·ClinicalTrials.gov·drugCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Polycystic Ovary Syndrome
Drug/Device/Intervention
Metformin
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
University of Cagliari
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2015
End date
May 01, 2022
Enrollment
168 participants
Primary outcome

Insulin resistance change in eighty hyperinsulinemic patients after metformin therapy and its discontinuation,Androgen levels change in eighty hyperinsulinemic patients after metformin therapy and its discontinuation

Summary

This study aimed to understand whether metformin therapy can improve insulin resistance in
 adolescent PCOS patients, both during treatment and after discontinuation, and to evaluate
 its action on the hormonal and metabolic pathways.

ICD-10 classifications
Polycystic ovarian syndromeOvarian dysfunction, unspecifiedOvarian dysfunctionOther ovarian dysfunctionNeoplasm of uncertain or unknown behaviour: Ovary
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06015594
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06015594 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Cagliari and is currently Completed. The study focuses on Polycystic Ovary Syndrome. Target enrollment is 168 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.